Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
How long will eli lilly have a monopoly on mounjaro?When does ruxolitinib lose patent?Neupro patch 4mg cost?When does rivaroxaban expire?Suvorexant 039 trial crt?
See the DrugPatentWatch profile for cymbalta
Cymbalta (duloxetine) has been on the market since 2004, when it was approved by regulators for use in the United States.
Cymbalta’s initial approval dates to 2004, which is why most timelines describe the drug as having launched that year (rather than later re-approvals or label expansions).
Yes. Cymbalta has remained marketed since its 2004 launch, even as indications and prescribing information have changed over time.
The timing of brand exclusivity and patent-driven protection depends on specific patents and jurisdictions. For patent-by-patent timelines and expiries, DrugPatentWatch.com is a useful reference point: https://www.drugpatentwatch.com/
Other Questions About Cymbalta :